Management of Elderly and Frail Patients with Comorbidities and Myelodysplastic Syndromes (MDS): A Case Study

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: June 26, 2015
Expiration Date: June 26, 2016

Expected time to complete this activity as designed: 30 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

Join Moreno Festuccia, MD, a hematologist within the Division of Hematology at the University of Turin in Italy who has been working at the Fred Hutchinson Cancer Research Center of Seattle in the Clinical Research Division – myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) team, since the end of June 2014 in a discussion of the appropriate management of elderly, poor performance status MDS patients. Using a real-world case, he will assist you in navigating the diagnosis and risk assessment of a newly diagnosed, elderly MDS patient, appropriate treatment planning tailored to the individual patient’s risk factors, appropriate monitoring, reassessment of risk and strategies to treat the patient accordingly while providing care that also focuses on quality of life throughout the life cycle of the disease.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in MDS.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Perform diagnosis and prognostic risk assessments appropriate for patients with MDS
  • Individualize active therapy planning according to a MDS patient’s risk factors and comorbidities with the goal of life prolongation in accordance with evidence-based guidelines
  • Recognize strategies appropriate for the care of unfit and/or elderly patients with MDS including considerations for quality of life


Management of Elderly and Frail Patients with Comorbidities and Myelodysplastic Syndromes (MDS): A Case Study – Moreno Festuccia, MD

Instructions for Participation and Credit

This activity is eligible for credit through June 26, 2016. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME credit may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Moreno Festuccia, MD
AOU City Health and Science of Turin
Division of Hematology
University of Torino
Torino Italy

Dr. Moreno Festuccia received his medical degree from University of Torino, School of Medicine, Italy. He completed his internship in hematology and bone marrow transplantation, his fellowship in bone marrow transplantation, and is pursing his residency in hematology at University of Torino, Italy.

Dr. Festuccia’s scientific interests include treatment of hematological malignancies, with a special focus on acute myeloid leukemia and allogeneic stem cell transplantation, as well as the management of life-treating complications after high-dose chemotherapy and statistical analysis of data.


Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.5 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-15-021-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Moreno Festuccia has disclosed no relevant financial relationships.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, and Eugene R. Tombler, PhD, FACME, medical director, oncology, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Festuccia has indicated that he does not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Festuccia has indicated that he does not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2015 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.